BLS Review/CPAP Flashcards
Albuterol (Adult Dose)
2.5 mg via nebulizer (repeat as needed)
Albuterol (Pediatric Dose)
< 2 years of age: 1.25 mg via nebulizer
>2 years of age: Use adult dosing
Albuterol (onset)
5-15 minutes
Albuterol (Peak Effect/Duration)
30-120 minutes, 3-6 hours
Albuterol (Brand Names)
Proventil, Ventolin, Proair, Accuneb
Albuterol (Class)
Beta 2 Agonist
Albuterol (Pharmacologic Action)
Beta 2 receptor agonist with some Beta 1 activity. Relaxes bronchial smooth muscle with little effect on heart rate
Albuterol (Indications)
Bronchospastic lung disease, Anaphylaxis with wheezing/respiratory distress. HYPERkalemia
Albuterol (Contraindications)
Hypersensitivity, tachycardia secondary to heart condition
Aspirin (Adult Dose)
162-324 mgs
Aspirin (Onset)
15-30 minutes
Aspirin (Peak Effect/Duration)
15-30 minutes, 1-2 hours
Aspirin (Class)
Antiplatelet agent, non-steroidal anti-inflammatory drug (NSAID)
Aspirin (Pharmacologic Action)
Inhibits synthesis of prostaglandin by cyclooxyrgenase; inhibits platelet aggregation; has antipyretic and
analgesic activity
Aspirin (Indications)
Antiplatelet agent for the care of patients suspected of suffering from an acute coronary syndrome
Aspirin (Contraindications)
Hypersensitivity to aspirin or NSAIDs (aspirin-associated hypersensitivity reactions include aspirin-induced
urticarial or aspirin-intolerant asthma), bleeding GI ulcers, hemolytic anemia from pyruvate kinase (PK) and
glucose-6-phosphate dehydrogenase (G6PD) deficiency, hemophilia, hemorrhagic diathesis, hemorrhoids,
lactating mother, nasal polyps associated with asthma, sarcoidosis, thrombocytopenia, ulcerative colitis
Epinephrine (Adult Dose) 1:1000
0.3 mgs IM
Epinephrine (Pedi Dose) 1:1000
0.15 mgs IM <25 kgs
Epinephrine (Onset) 1:1000
< 2 minutes
Epinephrine (Peak Effect/Duration) 1:1000
< 5 minutes, 5-10 minutes
Epinephrine (Class) 1:1000
Alpha/Beta adrenergic agonist
Epinephrine (Pharmacologic Action) 1:1000
Strong β-1-adrenergic effects, which cause an increase in cardiac contractility and heart rate, and a variable effect on
resulting in systemic vasoconstriction and increased vascular permeability. Strong β-2-adrenergic effects at lower doses
resulting in bronchial smooth muscle relaxation. Constriction of vascular smooth muscle via ⍺-1 receptors at moderate to
higher doses
Epinephrine (Indications) 1:1000
For use in the management of patients suffering anaphylaxis, shock, cardiac arrest, bradycardia, or in the nebulized for croup/bronchiolitis and IM form for refractory acute asthma
Epinephrine (Contraindications) 1:1000
Hypersensitivity, cardiac dilatation and coronary insufficiency
